ResearcherSeoul National UniversityActive in the last 2 years
Jun Suh Lee
Matched on ORCID iD 0000-0001-9487-9826; OpenAlex author ID A5025546800. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2021: 3 papers · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper
Papers 7
- Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, and Oral Immunosuppression. Co-author DOI 10.3390/medicina61040586↗
- Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery. Co-author DOI 10.5009/gnl230303↗
- Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 2017 International Consensus for Survival a… Co-author DOI 10.1245/s10434-022-13043-5↗
- Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. Co-author DOI 10.4251/wjgo.v15.i6.911↗
- Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma: An Analysis of Oncologic Outcomes According to the Recurrence Type. Co-author DOI 10.1097/as9.0000000000000096↗
- Impact of Acute Inflammation on the Survival Outcomes of Patients with Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1159/000520063↗
- Clinical Impact of Unexpected Para-Aortic Lymph Node Metastasis in Surgery for Resectable Pancreatic Cancer. Co-author DOI 10.3390/cancers13174454↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoo‐Seok Yoon · 7 shared papers, 2021–2025 · strength 1.32
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery. DOI 10.5009/gnl230303↗
- Paper Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. DOI 10.4251/wjgo.v15.i6.911↗
- Ho‐Seong Han · 7 shared papers, 2021–2025 · strength 1.32
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery. DOI 10.5009/gnl230303↗
- Paper Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. DOI 10.4251/wjgo.v15.i6.911↗
- Boram Lee · 4 shared papers, 2021–2025 · strength 0.83
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. DOI 10.4251/wjgo.v15.i6.911↗
- Paper Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma: An Analysis of Oncologic Outcomes Accord… DOI 10.1097/as9.0000000000000096↗
- Jai Young Cho · 3 shared papers, 2021–2025 · strength 0.60
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 201… DOI 10.1245/s10434-022-13043-5↗
- Paper Impact of Acute Inflammation on the Survival Outcomes of Patients with Resected Pancreatic Ductal Adenocarcinoma. DOI 10.1159/000520063↗
- Yeshong Park · 2 shared papers, 2023–2025 · strength 0.45
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 201… DOI 10.1245/s10434-022-13043-5↗
- MeeYoung Kang · 2 shared papers, 2023–2025 · strength 0.45
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 201… DOI 10.1245/s10434-022-13043-5↗
- Jong-Chan Lee · 2 shared papers, 2021–2024 · strength 0.33
- Kwangrok Jung · 2 shared papers, 2021–2024 · strength 0.33
- Jae Hyup Jung · 2 shared papers, 2021–2024 · strength 0.33
- Jin Won Kim · 1 shared paper, 2024 · strength 0.21
- Jin‐Hyeok Hwang · 1 shared paper, 2024 · strength 0.21
- Jaihwan Kim · 1 shared paper, 2024 · strength 0.21
- Roberto Ivan TROISI · 1 shared paper, 2023 · strength 0.19
- Fabrizio Panaro · 1 shared paper, 2023 · strength 0.19
- Gianluca Cassese · 1 shared paper, 2023 · strength 0.19
- Mohamed Rabie Saad · 1 shared paper, 2021 · strength 0.16
- Ahmed Shehta · 1 shared paper, 2021 · strength 0.16
- Ho-Kyoung Lee · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.